Replies to post #10095 on Momenta Pharmaceuticals, Inc. (MNTA)

[pollyvonwog]

I dunno go seek. Perhaps though! :)

MNTA is trading close to 10 because they are burning $20-24m a Q and keep losing every legal challenge they attempt. Going forward it will be whether the USSC takes the case and/or if M-copax can get approved. Not sure what the chart has to do with that. Maybe he's right. Maybe he's wrong.

[oldberkeley]

Just my two cents: I can see how TA could be a useful predictive tool for stocks of large, traditional companies engaged in some cyclical type of business, but for the life of me I can't see how it's useful with small, inherently unpredictable, event-driven biotechs.